Papillary endothelial hyperplasia (Masson's tumor) in children

A Liné1, J Sanchez2, L Jayyosi2

  • 1CHU de Reims, American Memorial Hospital, Chirurgie pédiatrique, 47, rue Cognacq-Jay, 51100 Reims, France.

Annales De Chirurgie Plastique Et Esthetique
|June 28, 2016
PubMed

Insights

Intravascular papillary endothelial hyperplasia (IPEH), or Masson's tumor, is a rare benign vascular tumor. This study highlights four pediatric cases, emphasizing diagnostic challenges and the need for histological confirmation in children.

Area of Science:

  • Vascular Oncology
  • Pediatric Pathology
  • Dermatopathology

Background:

  • Intravascular papillary endothelial hyperplasia (IPEH), also known as Masson's tumor, is a rare benign vascular proliferation.
  • Typically found in adults, IPEH primarily affects the skin and subcutaneous vessels, often on the face and limbs.

Observation:

  • This report details four pediatric cases of Masson's tumor with varied clinical presentations.
  • Tumors presented as painful subcutaneous masses (1-5 cm) in unusual pediatric locations: abdominal muscle, foot, thigh, and axilla.
  • Diagnostic imaging (MRI, Doppler ultrasound) was inconclusive, mimicking hematoma, lymphangioma, or hemangioma.

Findings:

  • Histological examination was crucial for definitive diagnosis, distinguishing IPEH from other vascular lesions.
  • Surgical excision was indicated due to pain or parental concern; incomplete resection led to a persistent residual lesion in one case.
  • The study underscores the potential for IPEH in pediatric patients, including atypical presentations and locations.

Implications:

  • Clinical suspicion for Masson's tumor should be raised in children presenting with sudden-onset, painful subcutaneous or intramuscular tumors with a vascular appearance.
  • Accurate diagnosis relies on differentiating IPEH from malignant conditions like angiosarcoma through histological analysis.
  • Early and complete surgical excision combined with histological confirmation is essential for managing pediatric Masson's tumors.